Ligand Pharmaceuticals Acquires XOMA Royalty for $739M, Doubling Portfolio to 200+ Biopharma Royalty Assets
Ligand Pharmaceuticals Completes \$739 Million Acquisition o...
Sign in to continue:
Ligand Pharmaceuticals Completes \$739 Million Acquisition o...
Genprex, Inc. Announces 1-for-22 Reverse Stock Split Amid Na...
Trex Company, Inc. Issues Clarification on Full-Year Adjuste...
OFA Group (Nasdaq: OFAL) 2026 Annual Report – Key Investor T...
UYSCU 2026 Annual Report: Key Investor Takeaways and Shareho...
Yuk Wing Group Major Acquisition: Investor Analysis Yu...
XXF Group Holdings Limited - Supplemental Announcement on Sa...
Sino-Ocean Group Announces June 2026 and 1H 2026 Unaudited O...
China Life Insurance Announces Substantial Profit Growth for...
Celestial Asia Securities Holdings Limited - Discloseable Tr...